by John Miller; Editing by Keith Weir | Oct 16, 2017 | BioPharma, Oncology
image: Roche building in Basel, Switzerland. ZURICH (Reuters) – Swiss drugmaker Roche’s Alecensa has been recommended for approval in Europe as a first-line treatment for mutated lung cancer, a key European Medicines Agency (ESA) experts panel said on Friday....
by Bill Berkrot | Oct 3, 2017 | BioPharma, Breast Cancer, Oncology
Source: Eli Lilly wins U.S. approval for breast cancer drug (Reuters) – The U.S. Food and Drug Administration said on Thursday it approved an Eli Lilly and Co drug to treat advanced breast cancer that has progressed following prior treatment. The drug,...
